Clinical Trials
3 trialsNCT03480776 2026-01-14
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
Canadian Cancer Trials Group
Phase 2 Active not recruiting
NCT02659384 2023-03-14
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT03192059 2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2 Completed